Oxysterols in bile acid metabolism

Clinica Chimica Acta

Volumn 412, Issue 23-24, 2011, Pages 2037-2045

  Crosignani, Andrea ^a   Zuin, Massimo ^a   Allocca, Mariangela ^a   Del Puppo, Marina ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

27 hydroxycholesterol; 7alpha hydroxycholesterol; Bile acid metabolism; Bile acid synthesis; Cholesterol metabolism; Oxysterols

Indexed keywords

25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 7ALPHA HYDROXYCHOLESTEROL; CHOLESTEROL DERIVATIVE; LIVER X RECEPTOR; OXYSTEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN;

BILE ACID METABOLISM; BILE ACID SYNTHESIS; BIOLOGICAL ACTIVITY; CEREBROTENDINOUS XANTHOMATOSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CYP7A1 GENE; CYP7B1 GENE; DISEASE ASSOCIATION; GENE; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; HUMAN; HYDROXYLATION; LIPOLYSIS; LIVER DISEASE; METABOLIC DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

BILE ACIDS AND SALTS; CHILD; HUMANS; LIVER DISEASES; METABOLIC DISEASES; PEDIATRICS; STEROLS;

EID: 80053631359     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.07.028     Document Type: Review

References (103)

1. De Fabiani E., Mitro N., Gilardi F., Crestani M. Sterol-protein interactions in cholesterol and bile acid synthesis. Subcell Biochem 2010, 51:109-135. J.R. Harris (Ed.).
2. Javitt N.B. Cholesterol, hydroxycholesterols, and bile acids. Biochem Biophys Res Commun 2002, 292:1147-1153.
3. Cohen J.C., Cali J.J., Jelinek D.F., et al. Cloning of the human cholesterol 7α-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12. Genomics 1992, 14:153-161.
4. Nitta M., Ku S., Brown C., Okamoto A.Y., Shan B. CPF: an orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7a-hydroxylase gene. Proc Nat Acad Sci U S A 1999, 9:6660-6665.
5. Chiang J.Y. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol 2004, 40:539-551.
6. Stroup D., Crestani M., Chiang J.Y. Identification of a bile acid response element in the cholesterol 7α-hydroxylase gene (CYP7A). Am J Physiol 1997, 273:G508-G517.
7. De Fabiani E., Mitro N., Anzulovich A.C., Pinelli A., Galli G., Crestani M. The negative effects of bile acids and tumor necrosis factor-alpha on the transcription of cholesterol 7α-hydroxylase gene (CYP7A1) converge to hepatocyte nuclear factor-4. A novel mechanism of feedback regulation of bile acid synthesis mediated by nuclear receptors. J Biol Chem 2001, 276:30708-30716.
8. Kerr T., Saeki S., Schneider M., et al. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev Cell 2002, 2:713-720.
9. Yu C., Wang F., Jin C., Huang X., McKeehan W.L. Independent repression of bile acid synthesis and activation of c-Jun N-terminal Kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids. J Biol Chem 2005, 280:17707-17714.
10. De Fabiani E., Mitro N., Gilardi F., Caruso D., Galli G., Crestani M. Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle. J Biol Chem 2003, 278:39124-39132.
11. Ishibashi S., Schwarz M., Frykman P.K., Herz J., Russell D.W. J Biol Chem 1996, 271:18017-18023.
12. Schwarz M., Lund E.G., Setchell K.D.R., et al. Disruption of cholesterol 7α-hydroxylase gene in mice. II. Bile acid deficiency is overcome by induction of oxysterol 7α-hydroxylase. J Biol Chem 1996, 271:18024-18031.
13. Schwarz M., Russell D.W., Dietschy J.M., Turley S.D. Alternate pathways of bile acid synthesis in the cholesterol 7α-hydroxylase knockout mouse are not upregulated by either cholesterol or cholestyramine feeding. J Lipid Res 2001, 42:1594-1603.
14. Arnon R., Yoshimura T., Reiss A., Budai K., Lefkowitch J.H., Javitt N.B. Cholesterol 7α-hydroxylase knockout mice: a model for monohydroxy bile acid-related neonatal cholestasis. Gastroenterology 1998, 115:1223-1228.
15. Shefer S., Erickson S.K., Lear S.R., Batta A.K., Salen G. Upregulation of hepatic cholesterol 27-hydroxylase (CYP27) activity and normal levels of hepatic cholesterol synthesis in cholesterol 7α-hydroxylase (CYP7A1) gene knockout mice. Gastroenterology 2000, 118:A998. (Abstr.).
16. Pikuleva I.A., Babiker A., Waterman M.R., Bjorkhem I. Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J Biol Chem 1998, 273:18153-18160.
17. Schwarz M., Lund E.G., Lathe R., Bjorkhem I., Russell D.W. Identification and characterization of a mouse oxysterol 7α-hydroxylase cDNA. J Biol Chem 1997, 272:23995-24001.
18. Cali J.J., Russell D.W. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reaction in bile acid biosynthesis. J Biol Chem 1991, 266:7774-7778.
19. Leitersdorf E., Meiner V. Cerebrotendinous xanthomatosis. Curr Opin Lipidol 1994, 5:138-142.
20. Vlahcevic Z.R., Jairath S.K., Heuman D.M., et al. Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am J Physiol 1996, 270(4 Pt 1):G646-G652.
21. Bjorkhem I., Araya Z., Rudling M., Angelin B., Einarsson C., Wikvall K. Differences in the regulation of the classical and the alternative pathway for bile acid synthesis in human liver. No coordinate regulation of CYP7A1 and CYP27A1. J Biol Chem 2002, 277:26804-26807.
22. Hua X., Nohturfft A., Goldstein J.L., Brown M.S. Sterol resistance in CHO cells traced to point mutation in SREBP cleavage-activating protein. Cell 1996, 87:415-426.
23. Costet P., Luo Y., Wang N., Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000, 275:28240-28245.
24. Venkateswaran A., Laffitte B.A., Joseph S.B., et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc Nat Acad Sci U S A 2000, 97:12097-12102.
25. Tontonoz P., Mangelsdorf D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003, 17:985-993.
26. Babiker A., Andersson O., Lund E., et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 1997, 272:26253-26261.
27. Vlahcevic Z.R., Stravitz R.T., Heuman D.M., Hylemon P.B., Pandak W.M. Quantitative estimations of the contribution of different bile acids pathways to total bile acid synthesis in the rat. Gastroenterology 1997, 113:1949-1957.
28. Xu G., Salen G., Shefer S., et al. Increasing dietary cholesterol induces different regulation of classic and alternative bile acid synthesis. J Clin Invest 1999, 103:89-95.
29. Lund E.G., Guileyardo J.M., Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Nat Acad Sci U S A 1999, 96:7238-7243.
30. Lutjohann D., Breuer O., Ahlborg G., et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Nat Acad Sci U S A 1996, 93:9799-9804.
31. Brown J., Theisler C., Silberman S., et al. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J Biol Chem 2004, 279:34674-34681.
32. Lutjohann D., Papassotiropoulos A., Bjorkhem I., et al. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J Lipid Res 2000, 41:195-198.
33. Schonknecht P., Lutjohann D., Pantel J., et al. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett 2002, 324:83-85.
34. Wang L., Schuster G.U., Hultenby K., Zhang Q., Andersson S., Gustafsson J.A. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc Nat Acad Sci U S A 2002, 99:13878-13883.
35. Adams C.M., Reitz J., De Brabander J.K., et al. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J Biol Chem 2004, 279:52772-52780.
36. Javitt N.B. 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles. J Lipid Res 2002, 43:665-670.
37. Bjorkhem I. Do oxysterols control cholesterol homeostasis?. J Clin Invest 2002, 110:725-730.
38. Brown M.S., Goldstein J.L. Sterol regulatory element binding proteins (SREBPs): controllers of lipid synthesis and cellular uptake. Nutr Rev 1998 Feb, 56(2 Pt 2). S1-3; discussion S54-75.
39. Brown M.S., Goldstein J.L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Nat Acad Sci U S A 1999, 96:11041-11048.
40. Briggs M.R., Yokoyama C., Wang X., Brown M.S., Goldstein J.L. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. I. Identification of the protein and delineation of its target nucleotide sequence. J Biol Chem 1993, 268:14490-14496.
41. Wang X., Briggs M.R., Hua X., Yokoyama C., Goldstein J.L., Brown M.S. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. II. Purification and characterization. J Biol Chem 1993, 268:14497-14504.
42. Nohturfft A., DeBose-Boyd R.A., Scheek S., Goldstein J.L., Brown M.S. Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi. Proc Natl Acad Sci USA 1999, 96:11235-11240.
43. Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., Goldstein J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 2007, 104:6511-6518.
44. Nohturfft A., Yabe D., Goldstein J.L., Brown M.S., Espenshade P.J. Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes. Cell 2000, 102:315-323.
45. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002, 109:1125-1131.
46. Gong Y., Lee J.N., Lee P.C., Goldstein J.L., Brown M.S., Ye J. Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake. Cell Metab 2006, 3:15-24.
47. Lee J.N., Song B., DeBose-Boyd R.A., Ye J. Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78. J Biol Chem 2006, 281:39308-39315.
48. Harik-Khan R., Holmes R.P. Estimation of 26-hydroxycholesterol in serum by high-performance liquid chromatography and its measurement in patients with atherosclerosis. J Steroid Biochem 1990, 36:351-355.
49. Del Puppo M., Kienle M.G., Petroni M.L., Crosignani A., Podda M. Serum 27-hydroxycholesterol in patients with primary biliary cirrhosis suggests alteration of cholesterol catabolism to bile acids via the acidic pathway. J Lipid Res 1998, 39:2477-2482.
50. Burkard I., von Eckardstein A., Waeber G., Vollenweider P., Rentsch K.M. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. Atherosclerosis 2007, 194:71-78.
51. Crosignani A., Del Puppo M., Longo M., et al. Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease. Clin Chim Acta 2007, 382:82-88.
52. Reiss A.B., Martin K.O., Rojer D.E., et al. Sterol 27-hydroxylase: expression in human arterial endothelium. J Lipid Res 1997, 38:1254-1260.
53. Björkhem I., Andersson O., Diczfalusy U., et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc Natl Acad Sci USA 1994, 91:8592-8596.
54. Fujiyama J., Kuriyama M., Arima S., et al. Atherogenic risk factors in cerebrotendinous xanthomatosis. Clin Chim Acta 1991, 200:1-11.
55. Weingärtner O., Laufs U., Böhm M., Lütjohann D. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. Atherosclerosis 2010, 209:39-41.
56. Del Puppo M., Crosignani A., Longo M., et al. A minimally invasive technique for the evaluation of the regulatory steps of the two major pathways of bile acid synthesis. Clin Chim Acta 2005, 355:23-31.
57. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003, 72:137-174.
58. Chiang J.Y., Kimmel R., Stroup D. Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 2001, 262:257-265.
59. Reihnér E., Björkhem I., Angelin B., Ewerth S., Einarsson K. Bile acid synthesis in humans: regulation of hepatic microsomal cholesterol 7 alpha-hydroxylase activity. Gastroenterology 1989, 97:1498-1505.
60. Makishima M., Okamoto A.Y., Repa J.J., et al. Identification of a nuclear receptor for bile acids. Science 1999, 284:1362-1365.
61. Javitt N.B. Hepatic bile formation. N Engl J Med 1464-9 and 1511-6, 295(26).
62. Lundåsen T., Gälman C., Angelin B., Rudling M. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J Intern Med 2006, 260:530-536.
63. Inagaki T., Choi M., Moschetta A., Peng L., Cummins C.L., McDonald J.G., Luo G., Jones S.A., Goodwin B., Richardson J.A., Gerard R.D., Repa J.J., Mangelsdorf D.J., Kliewer S.A. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2005, 2:217-225.
64. Song C., Liao S. Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology 2000, 141:4180-4184.
65. Anderson K.E., Kok E., Javitt N.B. Bile acid synthesis in man: metabolism of 7-hydroxycholesterol- 14C and 26-hydroxycholesterol- 3 H. J Clin Invest 1972, 51:112-117.
66. Quinn C.M., Jessup W., Wong J., Kritharides L., Brown A.J. Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands. Biochem J 2005, 385:823-830.
67. Szanto A., Benko S., Szatmari I., Balint B.L., Furtos I., Rühl R., Molnar S., Csiba L., Garuti R., Calandra S., Larsson H., Diczfalusy U., Nagy L. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol Cell Biol 2004, 24:8154-8166.
68. Wolfe R.R. Radioactive and stable isotope tracers in biomedicine. Principles and practice of kinetic analysis 1992, Wiley-Liss Inc, NY. R.R. Wolfe (Ed.).
69. Duane W.C., Javitt N.B. 27-hydroxycholesterol: production rates in normal human subjects. J Lipid Res 1999, 40:1194-1199.
70. Björkhem I., Reihner E., Angelin B., Ewerth S., Akerlund J.E., Einarsson K. On the possible use of serum level of 7α-hydroxycholesterol as a marker for increased activity of the cholesterol 7α-hydroxylase in humans. J Lipid Res 1987, 28:889-894.
71. Hahn C., Reichel C., von Bergmann K. Serum concentration of 7 alpha-hydroxycholesterol as an indicator of bile acid synthesis in humans. J Lipid Res 1995, 36:2059-2066.
72. Watkins J.B. Neonatal cholestasis: developmental aspects and current concepts. Semin Liver Dis 1993, 13:276-288.
73. Collins J.C., Altman P., Martin K.O., Javitt N.B. Neonatal cholestatic syndromes: molecular basis for transient or "physiologic cholestasis.". Hepatology 1994, 340A.
74. Setchell K.D., Schwarz M., O'Connell N.C., et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7α-hydroxylase gene causes severe neonatal liver disease. J Clin Invest 1998, 102:1690-1703.
75. Barbara L., Lazzari R., Roda A., et al. Serum bile acids in newborns and children. Pediatr Res 1980, 14:1222-1225.
76. Colombo C., Zuliani G., Ronchi M., Breidenstein J., Setchell K.D. Biliary bile acid composition of the human fetus in early gestation. Pediatr Res 1987, 21:197-200.
77. Setchell K.D., Dumaswala R., Colombo C., Ronchi M. Hepatic bile acid metabolism during early development revealed from the analysis of human fetal gallbladder bile. J Biol Chem 1988, 263:16637-16644.
78. Crosignani A., Podda M., Battezzati P.M., et al. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 1991, 14:1000-1007.
79. Invernizzi P., Setchell K.D., Crosignani A., et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology 1999, 29:320-327.
80. Crosignani A., Del Puppo M., De Fabiani E., et al. Plasma oxysterols in normal and cholestatic children as indicators of the two pathways of bile acid synthesis. Clin Chim Acta 2008, 395:84-88.
81. Leitersdorf E., Reshef A., Meiner V., et al. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J Clin Invest 1993, 91:2488-2496.
82. Panzenboeck U., Andersson U., Hansson M., Sattler W., Meaney S., Björkhem I. On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis. J Lipid Res 2007, 48:1167-1174.
83. Del Puppo M., Corna F., Dotti M.T., De Fabiani E., Galli Kienle M. In vivo evaluation of bile acid synthesis in patients with cerebrotendinous xanthomatosis. Chem Phys Lipids 2007, 149(Supplement 1):S75-S76.
84. Pullinger C.R., Eng C., Salen G., et al. Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest 2002, 110:109-117.
85. Benetti A., Del Puppo M., Crosignani A., et al. Assorbimento intestinale ed eliminazione del colesterolo nell'obesità e nei soggetti normopeso: effetto del calo ponderale con chirurgia bariatrica. Meeting SID 2010. Il Diabete 2010, 1(S1):35. (Abstr).
86. Longo M., Crosignani A., Battezzati P.M., et al. Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut 2002, 51:265-269.
87. Allocca M., Crosignani A., Gritti A., et al. Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut 2006, 55:1795-1800.
88. Del Puppo M., Galli Kienle M., Crosignani A., et al. Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. J Lipid Res 2001, 42:437-441.
89. Longo M., Crosignani A., Podda M. Hyperlipidemia in chronic cholestatic liver disease. Curr Treat Options Gastroenterol 2001, 4:111-114.
90. Goldman M., Vlahcevic Z.R., Schwartz C.C., Gustafsson J., Swell L. Bile acid metabolism in cirrhosis. VIII. Quantitative evaluation of bile acid synthesis from [7 beta-3H]7 alpha-hydroxycholesterol and [G-3H]26-hydroxycholesterol. Hepatology 1982, 2:59-66.
91. Dueland S., Reichen J., Everson G.T., Davis R.A. Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats. Biochem J 1991, 280:373-377.
92. Bertolotti M., Carulli L., Concari M., Martella P., Loria P., Tagliafico E., Ferrari S., Del Puppo M., Amati B., De Fabiani E., Crestani M., Amorotti C., Manenti A., Carubbi F., Pinetti A., Carulli N. Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans. Hepatology 2001, 34:234-242.
93. Okamoto S., Fukushima K., Higashijima H., Makino I., Kishinaka M., Oda H., Yamashita H., Ichimiya H., Chijiiwa K., Kuroki S. Serum 7 alpha-hydroxycholesterol reflects hepatic bile acid synthesis in patients with obstructive jaundice after external biliary drainage. Hepatology 1994, 20:95-100.
94. Schaap F.G., van der Gaag N.A., Gouma D.J., Jansen P.L. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 2009, 49:1228-1235.
95. Bertolotti M., Carulli N., Menozzi D., et al. In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment. J Lipid Res 1986, 27:1278-1286.
96. Ma K., Saha P.K., Chan L., Moore D.D. Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest 2006, 116:1102-1109.
97. Cariou B., van Harmelen K., Duran-Sandoval D., et al. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J Biol Chem 2006, 281:11039-11049.
98. Zhang Y., Lee F.Y., Barrera G., et al. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Nat Acad Sci U S A 2006, 103:1006-1011.
99. Goodwin B., Jones S.A., Price R.R., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 2000, 6:517-526.
100. Sinal C.J., Tohkin M., Miyata M., Ward J.M., Lambert G., Gonzalez F.J. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 2000, 102:731-744.
101. Lambert G., Amar M.J., Guo G., Brewer H.B., Gonzalez F.J., Sinal C.J. The farnesoid X-receptor is an essential regulator of cholesterol homeostasis. J Biol Chem 2003, 278:2563-2570.
102. Battezzati A., Benedini S., Fattorini A., et al. Insulin action on protein metabolism in acromegalic patients. Am J Physiol Endocrinol Metab 2003, 284:E823-E829.
103. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-E223.